Subscribe Join Our Facebook Group
MULTIMEDIA: Geoffrey Woo Topics

Subscribe to IEET Lists Daily News Feed
Longevity Dividend List
Catastrophic Risks List
Biopolitics of Popular Culture List
Technoprogressive List
Trans-Spirit List


Geoffrey Woo Topics
Rights > HealthLongevity > CognitiveLiberty > Vision > Contributors > Geoffrey Woo > Enablement > Psychology > Innovation > Neuroscience
Geoffrey Woo
Humans: The Next Platform by Geoffrey Woo

Biohacking and transhumanist advances (including nootropics, extended longevity, cybernetic implants, better behavioral and genetic self-understanding) will materially advance our quality of life and productivity in the coming decade, but we need to be thoughtful about the potential social and ethical pitfalls as we transform. Google Trends shows a marked uptick in searches for “nootropics” and related biohacking fields, so now is the time to have the conversation about the direction we’re headed.

Rights > HealthLongevity > CognitiveLiberty > Economic > GlobalDemocracySecurity > Vision > Contributors > Geoffrey Woo > Enablement > Technoprogressivism > Neuroscience > SciTech
Geoffrey Woo
Smart Regulation For Smart Drugs by Geoffrey Woo

“For the modern mad men and wolves of Wall Street, gone are the days of widespread day drinking and functional cocaine use. Instead, in this age of efficiency above all else, corporate climbers sometimes seek a simple brain boost, something to help them to get the job done without manic jitters or a nasty crash.

For that, they are turning to nootropics,” writes Jack Smith IV on the cover story for an April 2015 edition of the New York Observer.

Rights > HealthLongevity > CognitiveLiberty > Vision > Contributors > Geoffrey Woo > Enablement > Technoprogressivism > Innovation > Neuroscience
Geoffrey Woo
Nootropics Aren’t Just For Tech Millionaires by Geoffrey Woo

Nootropics, more colloquially known as “smart drugs,” are in the zeitgeist. Hollywood productions like Limitless and Lucy to a CNN profile of a tech millionaire - Dave Asprey - spending $300,000 to hack his own body with research chemicals have certainly raised the profile of nootropics in the mainstream.

This essay was co-written with Michael Brandt